Nitrosamines Updates!

With reference to the introduction of NDPA nitrosamine in the most recent EMA review, Neotron pharma supports customers with analytical screening or validation activities for the molecules reported or on specific molecules requests after risk assessment.

Find out more

Latest update: 04/03/2022 10:37:26

In the same section

This site uses cookies, including from third parties, to improve the browsing experience. If you want to know more you can consult our Cookie Policy . You can freely lend, refuse or withdraw your consent at any time by accessing the preferences panel. You can consent to the use of these technologies by consenting to this information.